what is in glp-1 for Weight Loss and Diabetes GLP-1 receptor agonists | How
Description
Compelling evidence from landmark clinical trials, particularly STEP-HFpEF, STEP-HFpEF DM and SUMMIT, has established the efficacy of GLP-1RAs in improving HF-related symptoms and quality of life, as well as reducing worsening HF events, in the prevalent phenotype of HFpEF in the setting of obesity and T2D
The most common side effects are nausea (~15%), diarrhea (~15%), and other gastrointestinal complaints
2023, pp
Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG
It is also ideal for patients who are not ready for surgery but want meaningful, visible improvement
The decision means discovery, pretrial motions, and potential settlement discussions will move forward
